81 FR 79030 - Agency Information Collection Activities; Proposed Collection; Comment Request; Electronic Products
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration Federal Register Volume 81, Issue 218 (November 10, 2016)
Food and Drug Administration
Federal Register Volume 81, Issue 218 (November 10, 2016)
| Page Range | 79030-79033 | |
| FR Document | 2016-27199 |
[Federal Register Volume 81, Number 218 (Thursday, November 10, 2016)] [Notices] [Pages 79030-79033] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-27199] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2013-N-0618] Agency Information Collection Activities; Proposed Collection; Comment Request; Electronic Products AGENCY: Food and Drug Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on requirements for reporting and recordkeeping, general and specific requirements, and the availability of sample electronic products for manufacturers and distributors of electronic products. DATES: Submit either electronic or written comments on the collection of information by January 9, 2017. ADDRESSES: You may submit comments as follows: Electronic Submissions Submit electronic comments in the following way:Federal eRulemaking Portal: http://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to http://www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else's Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on http://www.regulations.gov. If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see ``Written/Paper Submissions'' and ``Instructions''). Written/Paper Submissions Submit written/paper submissions as follows: Mail/Hand delivery/Courier (for written/paper submissions): Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. For written/paper comments submitted to the Division of Dockets Management, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in ``Instructions.'' Instructions: All submissions received must include the Docket No. FDA-2013-N-0618 for ``Agency Information Collection Activities; Proposed Collection; Comment Request; Electronic Products.'' Received comments will be placed in the docket and, except for those submitted as ``Confidential Submissions,'' publicly viewable at http://www.regulations.gov or at the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. Confidential Submissions--To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states ``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will review this copy, including the claimed confidential information, in its consideration of comments. The second copy, which will have the claimed confidential information redacted/blacked out, will be available for public viewing and posted on http://www.regulations.gov. Submit both copies to the Division of Dockets Management. If you do not wish your name and contact information to be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify this information as ``confidential.'' Any information marked as ``confidential'' will not be disclosed except in accordance with 21 CFR 10.20 and other applicable disclosure law. For more information about FDA's posting of comments to public dockets, see 80 FR 56469, September 18, 2015, or access the information at: http://www.fda.gov/regulatoryinformation/dockets/default.htm. Docket: For access to the docket to read background documents or the electronic and written/paper comments received, go to http://www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the ``Search'' box and follow the prompts and/or go to the Division of Dockets Management, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, Food and Drug Administration, Three White Flint North, 10A63, 11601 Landsdown St., North Bethesda, MD 20852, [email protected]. SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal Agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. ``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes Agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal Agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, FDA is publishing notice of the proposed collection of information set forth in this document. With respect to the following collection of information, FDA invites comments on these topics: (1) Whether the proposed collection of information is necessary for the proper performance of FDA's functions, including whether the information will have practical utility; (2) the accuracy of FDA's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques, [[Page 79031]] when appropriate, and other forms of information technology. Electronic Products--21 CFR parts 1002 Through 1010 (OMB Control Number 0910-0025)--Extension Under sections 532 through 542 of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 360ii through 360ss), FDA has the responsibility to protect the public from unnecessary exposure of radiation from electronic products. The regulations issued under these authorities are listed in Title 21 of the Code of Federal Regulations, chapter I, subchapter J, parts 1000 through 1050 (21 CFR parts 1000 through 1050). Section 532 of the FD&C Act directs the Secretary of the Department of Health and Human Services (the Secretary), to establish and carry out an electronic product radiation control program, including the development, issuance, and administration of performance standards to control the emission of electronic product radiation from electronic products. The program is designed to protect the public health and safety from electronic radiation, and the FD&C Act authorizes the Secretary to procure (by negotiation or otherwise) electronic products for research and testing purposes and to sell or otherwise dispose of such products. Section 534(g) of the FD&C Act directs the Secretary to review and evaluate industry testing programs on a continuing basis; and section 535(e) and (f) of the FD&C Act directs the Secretary to immediately notify manufacturers of, and ensure correction of, radiation defects or noncompliance with performance standards. Section 537(b) of the FD&C Act contains the authority to require manufacturers of electronic products to establish and maintain records (including testing records), make reports, and provide information to determine whether the manufacturer has acted in compliance. The regulations under parts 1002 through 1010 specify reports to be provided by manufacturers and distributors to FDA and records to be maintained in the event of an investigation of a safety concern or a product recall. FDA conducts laboratory compliance testing of products covered by regulations for product standards in parts 1020, 1030, 1040, and 1050. FDA details product-specific performance standards that specify information to be supplied with the product or require specific reports. The information collections are either specifically called for in the FD&C Act or were developed to aid the Agency in performing its obligations under the FD&C Act. The data reported to FDA and the records maintained are used by FDA and the industry to make decisions and take actions that protect the public from radiation hazards presented by electronic products. This information refers to the identification of, location of, operational characteristics of, quality assurance programs for, and problem identification and correction of electronic products. The data provided to users and others are intended to encourage actions to reduce or eliminate radiation exposures. FDA uses the following forms to aid respondents in the submission of information for this information collection: Form FDA 2579 ``Report of Assembly of a Diagnostic X-Ray System'' Form FDA 2767 ``Notice of Availability of Sample Electronic Product'' Form FDA 2877 ``Declaration for Imported Electronic Products Subject to Radiation Control Standards'' Form FDA 3649 ``Accidental Radiation Occurrence (ARO)'' Form FDA 3626 ``A Guide for the Submission of Initial Reports on Diagnostic X-Ray Systems and Their Major Components'' Form FDA 3627 ``Diagnostic X-Ray CT Products Radiation Safety Report'' Form FDA 3628 ``General Annual Report (Includes Medical, Analytical, and Industrial X-Ray Products Annual Report)'' Form FDA 3629 ``Abbreviated Report'' Form FDA 3630 ``Guide for Preparing Product Reports on Sunlamps and Sunlamp Products'' Form FDA 3631 ``Guide for Preparing Annual Reports on Radiation Safety Testing of Sunlamp Products'' Form FDA 3632 ``Guide for Preparing Product Reports on Lasers and Products Containing Lasers'' Form FDA 3633 ``General Variance Request'' Form FDA 3634 ``Television Products Annual Report'' Form FDA 3635 ``Laser Light Show Notification'' Form FDA 3636 ``Guide for Preparing Annual Reports on Radiation Safety Testing of Laser and Laser Light Show Products'' Form FDA 3637 ``Laser Original Equipment Manufacturer (OEM) Report'' Form FDA 3638 ``Guide for Filing Annual Reports for X-Ray Components and Systems'' Form FDA 3639 ``Guidance for the Submission of Cabinet X-Ray System Reports Pursuant to 21 CFR 1020.40'' Form FDA 3640 ``Reporting Guide for Laser Light Shows and Displays'' Form FDA 3147 ``Application for a Variance From 21 CFR 1040.11(c) for a Laser Light Show, Display, or Device'' Form FDA 3641 ``Cabinet X-Ray Annual Report'' Form FDA 3642 ``General Correspondence'' Form FDA 3643 ``Microwave Oven Products Annual Report'' Form FDA 3644 ``Guide for Preparing Product Reports for Ultrasonic Therapy Products'' Form FDA 3645 ``Guide for Preparing Annual Reports for Ultrasonic Therapy Products'' Form FDA 3646 ``Mercury Vapor Lamp Products Radiation Safety Report'' Form FDA 3647 ``Guide for Preparing Annual Reports on Radiation Safety Testing of Mercury Vapor Lamps'' Form FDA 3659 ``Reporting and Compliance Guide for Television Products'' Form FDA 3660 ``Guidance for Preparing Reports on Radiation Safety of Microwave Ovens'' Form FDA 3661 ``A Guide for the Submission of an Abbreviated Report on X-Ray Tables, Cradles, Film Changers or Cassette Holders Intended for Diagnostic Use'' Form FDA 3662 ``A Guide for the Submission of an Abbreviated Radiation Safety Report on Cephalometric Devices Intended for Diagnostic Use'' Form FDA 3663 ``Abbreviated Reports on Radiation Safety for Microwave Products (Other than Microwave Ovens)'' Form FDA 3801 ``Guide for Preparing Initial Reports and Model Change Reports on Medical Ultraviolet Lamps and Products Containing Such Lamps'' The respondents to this information collection are electronic product and x-ray manufacturers, importers, and assemblers. The burden estimates were derived by consultation with FDA and industry personnel, and are based on data collected from industry, including recent product report submissions. An evaluation of the type and scope of information requested was also used to derive some time estimates. FDA estimates the burden of this collection of information as follows: [[Page 79032]] Table 1--Estimated Annual Reporting Burden \1\ \2\ -------------------------------------------------------------------------------------------------------------------------------------------------------- Number of Activity/21 CFR section FDA form Number of responses per Total annual Average burden per Total hours respondents respondent responses response -------------------------------------------------------------------------------------------------------------------------------------------------------- Product reports--1002.10(a) through 3626--Diagnostic x-ray... 1,400 2.2 3,080 24.......................... 73,920 (k). 3627--CT x-ray........... 3639--Cabinet x-ray...... 3632--Laser.............. 3640--Laser light show... 3630--Sunlamp............ 3646--Mercury vapor lamp. 3644--Ultrasonic therapy. 3659--TV................. 3660--Microwave oven..... 3801--UV lamps........... Product safety or testing changes-- ......................... 480 2.5 1,200 0.5......................... 600 1002.11(a) and (b). (30 minutes)................ Abbreviated reports--1002.12.......... 3629--General abbreviated 60 1.8 108 5........................... 540 report. 3661--X-ray tables, etc.. 3662--Cephalometric device. 3663--Microwave products (non-oven). Annual reports--1002.13(a) and (b).... 3628--General............ 1,660 1.3 2,158 18.......................... 38,844 3634--TV................. 3638--Diagnostic x-ray... 3641--Cabinet x-ray...... 3643--Microwave oven..... 3636--Laser.............. 3631--Sunlamp............ 3647--Mercury vapor lamp. 3645--Ultrasonic therapy. Quarterly updates for new models-- ......................... 120 1.4 168 0.5......................... 84 1002.13(c). (30 minutes)................ Accidental radiation occurrence 3649--ARO................ 30 6.7 201 2........................... 402 reports--1002.20. Exemption requests--1002.50(a) and 3642--General 4 1.3 5 1........................... 5 1002.51. correspondence. Product and sample information-- 2767--Sample product..... 5 1 5 0.1......................... 1 1005.10. (6 minutes)................. Identification information and 2877--Imports declaration 12,620 2.5 31,550 0.2......................... 6,310 compliance status--1005.25. (12 minutes)................ Alternate means of certification-- ......................... 1 2 2 5........................... 10 1010.2(d). Variance--1010.4(b)................... 3633--General variance 350 1.1 385 1.2......................... 462 request. (1 hour and 12 minutes)..... 3147--Laser show variance request. 3635--Laser show notification. Exemption from performance standards-- ......................... 1 1 1 22.......................... 22 1010.5(c) and (d). Alternate test procedures--1010.13.... ......................... 1 1 1 10.......................... 10 Report of assembly of diagnostic x-ray 2579--Assembler report... 1,230 34 41,820 0.30........................ 12,546 components--1020.30(d), (d)(1), and (18 minutes)................ (2). Microwave oven exemption from warning ......................... 1 1 1 1........................... 1 labels--1030.10(c)(6)(iv). Laser products registration-- 3637--Original equipment 70 2.9 203 3........................... 609 1040.10(a)(3)(i). manufacturer (OEM) report. -------------------------------------------------------------------------------------- Total................................. ......................... ............ .............. ............ ............................ 134,366 -------------------------------------------------------------------------------------------------------------------------------------------------------- \1\ There are no capital costs or operating and maintenance costs associated with this collection of information. \2\ Numbers have been rounded. [[Page 79033]] Table 2--Estimated Annual Recordkeeping Burden 1 2 ---------------------------------------------------------------------------------------------------------------- Number of Activity/21 CFR section Number of records per Total annual Average burden Total hours recordkeepers recordkeeper records per recordkeeping ---------------------------------------------------------------------------------------------------------------- Manufacturers records-- 1,650 1,650 2,722,500 0.12.............. 326,700 1002.30 and 1002.31(a). (7 minutes)....... Dealer/distributor records-- 3,110 50 155,500 0.05.............. 7,775 1002.40 and 1002.41. (30 minutes)...... Information on diagnostic x- 50 1 50 0.5............... 25 ray systems--1020.30(g). (30 minutes)...... Laser products distribution 70 1 70 1................. 70 records--1040.10(a)(3)(ii). ----------------------------------------------------------------------------------- Total................... .............. .............. .............. .................. 334,570 ---------------------------------------------------------------------------------------------------------------- \1\ There are no capital costs or operating and maintenance costs associated with this collection of information. \2\ Numbers have been rounded. Table 3--Estimated Annual Third-Party Disclosure Burden 1 2 ---------------------------------------------------------------------------------------------------------------- Number of Number of disclosures Total annual Average Activity/21 CFR section respondents per disclosures burden per Total hours respondent disclosure ---------------------------------------------------------------------------------------------------------------- Technical and safety information 1 1 1 12 12 for users--1002.3.............. Dealer/distributor records-- 30 3 90 1 90 1002.40 and 1002.41............ Television receiver critical 1 1 1 1 1 component warning-- 1020.10(c)(4).................. Cold cathode tubes-- 1 1 1 1 1 1020.20(c)(4).................. Information on diagnostic x-ray 6 1 6 55 330 systems--1020.30(g)............ Statement of maximum line 6 1 6 10 60 current of x-ray systems-- 1020.30(g)(2).................. Diagnostic x-ray system safety 6 1 6 200 1,200 and technical information-- 1020.30(h)(1) through (4)...... Fluoroscopic x-ray system safety 5 1 5 25 125 and technical information-- 1020.30(h)(5) and (6) and 1020.32(a)(1), (g), and (j)(4). CT equipment--1020.33(c), (d), 5 1 5 150 750 (g)(4), and (j)................ Cabinet x-ray systems 6 1 6 40 240 information--1020.40(c)(9)(i) and (ii)....................... Microwave oven radiation safety 1 1 1 20 20 instructions--1030.10(c)(4).... Microwave oven safety 1 1 1 20 20 information and instructions-- 1030.10(c)(5)(i) through (iv).. Microwave oven warning labels-- 1 1 1 1 1 1030.10(c)(6)(iii)............. Laser products information-- 3 1 3 20 60 1040.10(h)(1)(i) through (vi).. Laser product service 3 1 3 20 60 information--1040.10(h)(2)(i) and (ii)....................... Medical laser product 2 1 2 10 20 instructions--1040.11(a)(2).... Sunlamp products instructions-- 1 1 1 10 10 1040.20........................ Mercury vapor lamp labeling-- 1 1 1 1 1 1040.30(c)(1)(ii).............. Mercury vapor lamp permanently 1 1 1 1 1 affixed labels--1040.30(c)(2).. Ultrasonic therapy products-- 1 1 1 56 56 1050.10(d)(1) through (4), (f)(1), and (f)(2)(iii)........ ------------------------------------------------------------------------------- Total........................... .............. .............. .............. .............. 3,058 ---------------------------------------------------------------------------------------------------------------- \1\ There are no capital costs or operating and maintenance costs associated with this collection of information. \2\ Numbers have been rounded. Dated: November 4, 2016. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2016-27199 Filed 11-9-16; 8:45 am] BILLING CODE 4164-01-P
![79030 Federal Register / Vol. 81, No. 218 / Thursday, November 10, 2016 / Notices
Dated: November 4, 2016. identifies you in the body of your accordance with 21 CFR 10.20 and other
Leslie Kux, comments, that information will be applicable disclosure law. For more
Associate Commissioner for Policy. posted on http://www.regulations.gov. information about FDA’s posting of
[FR Doc. 2016–27106 Filed 11–9–16; 8:45 am] • If you want to submit a comment comments to public dockets, see 80 FR
BILLING CODE 4164–01–P
with confidential information that you 56469, September 18, 2015, or access
do not wish to be made available to the the information at: http://www.fda.gov/
public, submit the comment as a regulatoryinformation/dockets/
DEPARTMENT OF HEALTH AND written/paper submission and in the default.htm.
HUMAN SERVICES manner detailed (see ‘‘Written/Paper Docket: For access to the docket to
Submissions’’ and ‘‘Instructions’’). read background documents or the
Food and Drug Administration electronic and written/paper comments
Written/Paper Submissions
[Docket No. FDA–2013–N–0618] Submit written/paper submissions as received, go to http://
follows: www.regulations.gov and insert the
Agency Information Collection docket number, found in brackets in the
• Mail/Hand delivery/Courier (for
Activities; Proposed Collection; heading of this document, into the
written/paper submissions): Division of
Comment Request; Electronic ‘‘Search’’ box and follow the prompts
Dockets Management (HFA–305), Food
Products and/or go to the Division of Dockets
and Drug Administration, 5630 Fishers
AGENCY: Food and Drug Administration, Lane, Rm. 1061, Rockville, MD 20852. Management, 5630 Fishers Lane, Rm.
HHS. • For written/paper comments 1061, Rockville, MD 20852.
ACTION: Notice. submitted to the Division of Dockets FOR FURTHER INFORMATION CONTACT: FDA
Management, FDA will post your PRA Staff, Office of Operations, Food
SUMMARY: The Food and Drug comment, as well as any attachments, and Drug Administration, Three White
Administration (FDA) is announcing an except for information submitted, Flint North, 10A63, 11601 Landsdown
opportunity for public comment on the marked and identified, as confidential, St., North Bethesda, MD 20852,
proposed collection of certain if submitted as detailed in PRAStaff@fda.hhs.gov.
information by the Agency. Under the ‘‘Instructions.’’
Paperwork Reduction Act of 1995 (the Instructions: All submissions received SUPPLEMENTARY INFORMATION: Under the
PRA), Federal Agencies are required to must include the Docket No. FDA– PRA (44 U.S.C. 3501–3520), Federal
publish notice in the Federal Register 2013–N–0618 for ‘‘Agency Information Agencies must obtain approval from the
concerning each proposed collection of Collection Activities; Proposed Office of Management and Budget
information, including each proposed Collection; Comment Request; (OMB) for each collection of
extension of an existing collection of Electronic Products.’’ Received information they conduct or sponsor.
information, and to allow 60 days for comments will be placed in the docket ‘‘Collection of information’’ is defined
public comment in response to the and, except for those submitted as in 44 U.S.C. 3502(3) and 5 CFR
notice. This notice solicits comments on ‘‘Confidential Submissions,’’ publicly 1320.3(c) and includes Agency requests
requirements for reporting and viewable at http://www.regulations.gov or requirements that members of the
recordkeeping, general and specific or at the Division of Dockets public submit reports, keep records, or
requirements, and the availability of Management between 9 a.m. and 4 p.m., provide information to a third party.
sample electronic products for Monday through Friday. Section 3506(c)(2)(A) of the PRA (44
manufacturers and distributors of • Confidential Submissions—To U.S.C. 3506(c)(2)(A)) requires Federal
electronic products. submit a comment with confidential Agencies to provide a 60-day notice in
DATES: Submit either electronic or information that you do not wish to be the Federal Register concerning each
written comments on the collection of made publicly available, submit your proposed collection of information,
information by January 9, 2017. comments only as a written/paper including each proposed extension of an
submission. You should submit two existing collection of information,
ADDRESSES: You may submit comments
copies total. One copy will include the before submitting the collection to OMB
as follows:
information you claim to be confidential for approval. To comply with this
Electronic Submissions with a heading or cover note that states requirement, FDA is publishing notice
Submit electronic comments in the ‘‘THIS DOCUMENT CONTAINS of the proposed collection of
following way: CONFIDENTIAL INFORMATION.’’ The information set forth in this document.
• Federal eRulemaking Portal: http:// Agency will review this copy, including With respect to the following
www.regulations.gov. Follow the the claimed confidential information, in collection of information, FDA invites
instructions for submitting comments. its consideration of comments. The comments on these topics: (1) Whether
Comments submitted electronically, second copy, which will have the the proposed collection of information
including attachments, to http:// claimed confidential information is necessary for the proper performance
www.regulations.gov will be posted to redacted/blacked out, will be available of FDA’s functions, including whether
the docket unchanged. Because your for public viewing and posted on http:// the information will have practical
comment will be made public, you are www.regulations.gov. Submit both utility; (2) the accuracy of FDA’s
solely responsible for ensuring that your copies to the Division of Dockets estimate of the burden of the proposed
comment does not include any Management. If you do not wish your collection of information, including the
asabaliauskas on DSK3SPTVN1PROD with NOTICES
confidential information that you or a name and contact information to be validity of the methodology and
third party may not wish to be posted, made publicly available, you can assumptions used; (3) ways to enhance
such as medical information, your or provide this information on the cover the quality, utility, and clarity of the
anyone else’s Social Security number, or sheet and not in the body of your information to be collected; and (4)
confidential business information, such comments and you must identify this ways to minimize the burden of the
as a manufacturing process. Please note information as ‘‘confidential.’’ Any collection of information on
that if you include your name, contact information marked as ‘‘confidential’’ respondents, including through the use
information, or other information that will not be disclosed except in of automated collection techniques,
VerDate Sep<11>2014 17:46 Nov 09, 2016 Jkt 241001 PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 E:\FR\FM\10NON1.SGM 10NON1](https://thefederalregister.org/doc/81_FR_79248/page/1.svg)
![Federal Register / Vol. 81, No. 218 / Thursday, November 10, 2016 / Notices 79033
TABLE 2—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1 2
Number of Average
Number of Total annual Total
Activity/21 CFR section records per burden per
recordkeepers records hours
recordkeeper recordkeeping
Manufacturers records—1002.30 and 1002.31(a) .............. 1,650 1,650 2,722,500 0.12 ................ 326,700
(7 minutes) .....
Dealer/distributor records—1002.40 and 1002.41 .............. 3,110 50 155,500 0.05 ................ 7,775
(30 minutes) ...
Information on diagnostic x-ray systems—1020.30(g) ........ 50 1 50 0.5 .................. 25
(30 minutes) ...
Laser products distribution records—1040.10(a)(3)(ii) ........ 70 1 70 1 ..................... 70
Total .............................................................................. ........................ ........................ ........................ ........................ 334,570
1 There are no capital costs or operating and maintenance costs associated with this collection of information.
2 Numbers have been rounded.
TABLE 3—ESTIMATED ANNUAL THIRD-PARTY DISCLOSURE BURDEN 1 2
Number of Average
Number of disclosures Total annual
Activity/21 CFR section burden per Total hours
respondents per disclosures disclosure
respondent
Technical and safety information for users—1002.3 ........... 1 1 1 12 12
Dealer/distributor records—1002.40 and 1002.41 ............... 30 3 90 1 90
Television receiver critical component warning—
1020.10(c)(4) .................................................................... 1 1 1 1 1
Cold cathode tubes—1020.20(c)(4) ..................................... 1 1 1 1 1
Information on diagnostic x-ray systems—1020.30(g) ........ 6 1 6 55 330
Statement of maximum line current of x-ray systems—
1020.30(g)(2) .................................................................... 6 1 6 10 60
Diagnostic x-ray system safety and technical information—
1020.30(h)(1) through (4) ................................................. 6 1 6 200 1,200
Fluoroscopic x-ray system safety and technical informa-
tion—1020.30(h)(5) and (6) and 1020.32(a)(1), (g), and
(j)(4) .................................................................................. 5 1 5 25 125
CT equipment—1020.33(c), (d), (g)(4), and (j) ................... 5 1 5 150 750
Cabinet x-ray systems information—1020.40(c)(9)(i) and
(ii) ...................................................................................... 6 1 6 40 240
Microwave oven radiation safety instructions—
1030.10(c)(4) .................................................................... 1 1 1 20 20
Microwave oven safety information and instructions—
1030.10(c)(5)(i) through (iv) ............................................. 1 1 1 20 20
Microwave oven warning labels—1030.10(c)(6)(iii) ............. 1 1 1 1 1
Laser products information—1040.10(h)(1)(i) through (vi) .. 3 1 3 20 60
Laser product service information—1040.10(h)(2)(i) and (ii) 3 1 3 20 60
Medical laser product instructions—1040.11(a)(2) .............. 2 1 2 10 20
Sunlamp products instructions—1040.20 ............................ 1 1 1 10 10
Mercury vapor lamp labeling—1040.30(c)(1)(ii) .................. 1 1 1 1 1
Mercury vapor lamp permanently affixed labels—
1040.30(c)(2) .................................................................... 1 1 1 1 1
Ultrasonic therapy products—1050.10(d)(1) through (4),
(f)(1), and (f)(2)(iii) ............................................................ 1 1 1 56 56
Total ..................................................................................... ........................ ........................ ........................ ........................ 3,058
1 There are no capital costs or operating and maintenance costs associated with this collection of information.
2 Numbers have been rounded.
Dated: November 4, 2016.
Leslie Kux,
Associate Commissioner for Policy.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
[FR Doc. 2016–27199 Filed 11–9–16; 8:45 am]
BILLING CODE 4164–01–P
VerDate Sep<11>2014 20:51 Nov 09, 2016 Jkt 241001 PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 E:\FR\FM\10NON1.SGM 10NON1](https://thefederalregister.org/doc/81_FR_79248/page/4.svg)
Document Created: 2016-11-10 01:43:47
Document Modified: 2016-11-10 01:43:47
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Dates | Submit either electronic or written comments on the collection of information by January 9, 2017. | |
| Contact | FDA PRA Staff, Office of Operations, Food and Drug Administration, Three White Flint North, 10A63, 11601 Landsdown St., North Bethesda, MD 20852, [email protected] | |
| FR Citation | 81 FR 79030 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR